Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
rTMS-COG
- Development stage
- Preclinical
- Administration
- Transcranial
01
Overview
rTMS-COG refers to a specific protocol or application of repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training, primarily investigated for the treatment of cognitive impairment in conditions such as Alzheimer’s disease. The approach involves delivering repeated magnetic pulses to targeted brain regions using an electromagnetic coil placed on the scalp, which induces electrical currents in underlying neural tissue and modulates neuronal activity. In the context of "COG," this typically means pairing rTMS with cognitive exercises or interventions aimed at enhancing memory, attention, or other cognitive functions[6][8]. This noninvasive therapy is considered safe and has shown promise in improving cognitive scores in clinical trials involving patients with mild-to-moderate Alzheimer’s disease[6][8].
Beyond the preview
Go deeper on rTMS-COG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on rTMS-COG.